View Author
stent patient group study lesion sirolimus-eluting trial target sirolimus-eluting stents artery revascularization restenosi follow-up percent target lesion stent thrombosis vessel month event luminal diameter treatment circulation diameter angiographic ravel stenosi randomized procedure death sirolimus-eluting stent result control group luminal sirolimu 5 years difference sirolimus-eluting stent group thrombosis infarction implantation in-stent copyright 2002 massachusetts point angina 3 years sirolimus-stent group survival in-stent restenosis table standard-stent group sousa control drug-eluting percutaneou france randomized comparison neointimal www.nejm.org intravascular right ultrasound finition morice target vessel comparison serruy 50 percent luminal loss 5- year outcomes sirolimus-stent target lesion revascularization device popma jj october index drug-eluting stents standard-stent stenting <0.001 percentage
3 Most Recent Publications
|
Long-Term Clinical Outcomes With Sirolimus-Eluting Coronary Stents. Five-Year Results of the RAVEL Trial
(Article)
Morice, M-C. Serruys, P.W.J.C. Barragan, P. Bode, C. Es, G.A. van Stoll, H.P. Snead, D. Mauri, L. Cutlip, D.E. Sousa, E. |
2007-10-01
|
|
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial.
(Article)
Fajadet, J. Morice, M-C. Laarman, G-J. Perin, M.A. Sousa, J.E. Schuler, G. Molnar, F. Guagliumi, G. Colombo, A. Ban Hayashi, E. Wülfert, E. Barragan, P. Serruys, P.W.J.C. Wijns, W. Constantini, C. Guermonprez, J-L. Eltchaninoff, H. Blanchard, D. Bartorelli, A. |
2005-03-01
|
|
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
(Article)
Morice, M-C. Guagliumi, G. Barragan, P. Serruys, P.W.J.C. Falotico, R. Molnar, F. Sousa, J.E. Fajadet, J. Ban Hayashi, E. Perin, M.A. Colombo, A. Schuler, G. |
2002-01-01
|
